Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7482443
Reference Type
Journal Article
Title
Malignant Tumors of the Female Reproductive System
Author(s)
Weiderpass, E; Hashim, D; Labrèche, F; ,
Year
2020
Publisher
Springer International Publishing
Location
Cham
Book Title
Occupational Cancers
Page Numbers
439-453
Language
English
DOI
10.1007/978-3-030-30766-0_25
URL
http://link.springer.com/10.1007/978-3-030-30766-0_25
Exit
Abstract
Cancers of the female reproductive system-namely, cancer of the cervix uteri (cervical cancer); cancer of the corpus uteri (which includes mostly adenocarcinomas originating in the endometrium and some other rarer cancers, such as sarcomas); ovarian, vulvar, vaginal, and fallopian tube cancers; and choriocarcinoma-are an important cause of cancer morbidity and mortality worldwide. Cervical, endometrial, and ovarian cancers are relatively common, while the other cancers of the female reproductive system are very rare. The only agent considered to be carcinogenic to the female reproductive system with sufficient evidence in humans is asbestos, classified as a carcinogen for the human ovary. Exposure to other agents with sufficient evidence of carcinogenicity generally occurs through medical treatments (diethylstilbestrol, oral contraceptives or hormone replacement therapy, X-radiation, and γ-radiation), environmental exposure (atomic bomb survivors), personal lifestyle habits (smoking, perineal use of talc-based body powder), or infections with viruses, namely, human immunodeficiency virus-1 (HIV1) and several human papilloma virus (HPV) types. © Springer Nature Switzerland AG 2020.
Keywords
Asbestos; Cervical cancer; Endometrial cancer; Fallopian tube; Occupational exposures; Ovarian cancer
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity